-transparent.png){kind=logo}
A controlled, single-blind trial was carried out in 10 hypertensive patients to compare the effectiveness of a single daily dose (2.5 mg to 5 mg) of indapamide with that of placebo. Blood pressure was measured with a bias-free sphygmomanometer. Indapamide produced a significant reduction in mean systolic and diastolic pressures in both supine and erect positions. It was generally well tolerated: few side-effects were reported and no significant changes were noted in laboratory tests. It is concluded that further long-term studies of indapamide are indicated in larger numbers of patients.
Related Publications
P Turner, and
G N Volans, and
H J Rogers
May 1983,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
P Turner, and
G N Volans, and
H J Rogers
March 1977,
Minerva medica,
P Turner, and
G N Volans, and
H J Rogers
November 1977,
Minerva medica,
P Turner, and
G N Volans, and
H J Rogers
January 1978,
Bollettino della Societa italiana di cardiologia,
P Turner, and
G N Volans, and
H J Rogers
January 1989,
Indian journal of physiology and pharmacology,
P Turner, and
G N Volans, and
H J Rogers
October 1987,
Minerva cardioangiologica,
P Turner, and
G N Volans, and
H J Rogers
October 1977,
Irish medical journal,
P Turner, and
G N Volans, and
H J Rogers
March 1962,
Journal of the Mississippi State Medical Association,
P Turner, and
G N Volans, and
H J Rogers
January 1983,
Current medical research and opinion,
P Turner, and
G N Volans, and
H J Rogers
February 1984,
The Medical letter on drugs and therapeutics,
